Sirius Medical Secures €10M to Enhance Cancer Treatment Technology
Eindhoven, Tuesday, 4 February 2025.
Sirius Medical obtained €10 million funding on World Cancer Day to expand its tumor localization technology, Apollo, enhancing global healthtech presence with significant growth potential in new markets.
Investment and Technology Impact
Sirius Medical, a pioneering healthtech company based in Eindhoven, has secured €10 million in scale-up funding led by Invest-NL with support from multiple investors including Nextgen Ventures and De Groot Family Office [1][2]. The funding announcement, strategically made on World Cancer Day 2025, follows a previous €12 million Series B round from approximately two years ago [1]. This medical device company has already demonstrated significant impact with their Pintuition technology, successfully implementing over 35,000 procedures across 250 active centers in Western Europe and the United States [1][2].
Revolutionary Cancer Surgery Navigation
The company’s flagship technology, the Sirius Pintuition system, represents a significant advancement in cancer surgery navigation, particularly for breast-conserving procedures. The system provides real-time distance and directional data for tumor localization [2], making it easier for surgeons to precisely target and remove tumors. The technology has gained both CE marking and FDA clearance [1], validating its safety and effectiveness for medical use. As highlighted by Karin Steffens, senior investment manager at Invest-NL, this innovation aligns with their mission to ‘avoid, replace, or relocate expensive care’ [1].
Strategic Expansion Plans
Under the leadership of CEO Bram Schermers, Sirius Medical plans to utilize this new funding to enhance both the Pintuition system and its complementary GPSDetect software [1][2]. ‘Announcing this funding milestone on World Cancer Day underscores the urgency of our mission to improve cancer care globally,’ states Schermers [1][4]. The investment will support improvements in usability and expand applications while accelerating the company’s sales infrastructure for market expansion [1]. According to Roel Dekkers from Nextgen Ventures, the company is well-positioned for expansion into untapped markets [2].